Upcoming Webinar: Closing the Gaps in Diabetes Care: Emerging Tools and Approaches
In 2021, PRECISIONvalue launched a proprietary survey of the care management ecosystem (including payers and health systems) and found diabetes to be one of the top conditions for which individuals are referred for care management.
Upcoming Webinar: The Power of Partnering to Support Healthcare Innovation and Improve Human Health
Join us on October 26th at 12:00pm EDT for a new Precision webinar in partnership with MedStar Health, a nationally-recognized leader in the integration and application of real world data analytics.
HLTH Boston 2021: Driving Diversity in Clinical Trials
Want to hear what life sciences leaders are doing to ensure diversity is deeply ingrained into the planning and execution of all clinical trials, leaving bias in the past? Don’t miss “Driving Diversity in Clinical Trials” at HLTH Boston 2021, moderated by Precision’s Mark Clein Sunday, October 17, 3:10PM ET.
Upcoming Webinar: Forging Patient Connections: How Evidence-Based Technologies Are Expanding Access and Adherence
Join us on Thursday, 10/21 @ 1:00 PM ET for this engaging webinar with PQA Quality Forum, featuring PRECISIONvalue’s Maureen Hennessey.
Miss any of our Recent Precision Value & Health Events? Check out our October Events Calendar
Miss any of our recent Precision Value & Health events? Check out our monthly marketing activities calendar to catch up on-demand, and stay ahead of upcoming dates!
Digital Pharma East
Are you attending Digital Pharma East this year? Whether you’re virtual or in-person, don’t miss Precision’s Jon Bambalas chairing the Data and Analytics Track, Thursday 9/30 from 9:30am-12:50pm ET, and speaking as a panelist for the presentation: Accelerate the Value of Data: Explore Different Models for Collecting and Operationalizing Data starting at 12:10pm ET.
Impact of NextGen Access Decision Makers on Health Care Services and Therapies
In the midst of the pandemic uncertainties, organizations are continuing their quest for value-based care. Precision’s Elizabeth Oyekan and Dominic Galante discuss who will be the next generation access decision makers to successfully take the Triple Aim premise of value-based care, couple it with lessons learned from the pandemic, scale it up, and sustain success over time to make a palpable difference in the US healthcare system.
(more…)
Alliance for Regenerative Medicine’s (ARM) Meeting on the Mesa Workshop: What’s Next for Advanced Therapies?
Panel Discussion sponsored by Precision ADVANCE
Tuesday, October 12, 7:15 – 8:45am PST | BlueRock Therapeutics Ballroom
On-Demand Webinar: How to speed up patient access to innovation: Strategies to convert early European regulatory approval into optimal reimbursement
In Europe, Conditional Marketing Authorisation (CMA) offers an earlier regulatory nod from the European Medicines Agency (EMA) with lower data requirements than full approval, and with it, the opportunity for gaining earlier patient access. But Health Technology Assessment (HTA) bodies have scrutinized subsequent national-level evidence submissions and have often awarded sub-optimal reimbursement outcomes. This results in inequalities in patient access and impacts the incentives for manufacturers to continue to innovate. So what to do?
Webinar: Pricing Strategies for Advanced Therapies
There is no doubt that the advanced therapies sector is growing at an exponential rate. According to a recently published 2021 Report by ARM (Alliance for Regenerative Medicine), the sector has raised $14.1B in financing in the first half of 2021 which is already 71% of what was raised in all of 2020. In addition, there are over 2,600 advance therapy clinical trials being conducted with 264 of those trails being Phase 3 trials and another 1,500 being Phase 2 trials.